Inogen (INGN) Acquisitions (2017)

Inogen (INGN) reported Acquisitions of $47000.0 for Q4 2017, up 840.0% quarter-over-quarter from $5000.0 in Q3 2017.

Inogen (INGN) Acquisitions (2017) Analysis & Trends

Inogen (INGN) has 1 years of Acquisitions data on file, last reported at $47000.0 in Q4 2017.

  • Acquisitions for Q4 2017 came in at $47000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $52000.0 (changed N/A YoY), and the FY2023 annual result was $29.6 million, changed N/A from the prior year.
  • Acquisitions advanced to $47000.0 in Q4 2017 per INGN's latest filing, from $5000.0 in the prior quarter.
  • Over five years, Acquisitions peaked at $47000.0 in Q4 2017 and troughed at $5000.0 in Q3 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 2.30 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Inogen 176.23 Mn 81.82 Mn 37.86 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 47,000.00
Sep 30, 2017 5,000.00